Literature DB >> 9252375

Chemical and immunological assay of the nonreducing terminal residues of chondroitin sulfate from human aggrecan.

A H Plaas1, S Wong-Palms, P J Roughley, R J Midura, V C Hascall.   

Abstract

Samples of aggrecan chondroitin sulfate, isolated from normal human knee cartilages of individuals from fetal to 72 years of age, were digested with chondroitin lyases. The products were analyzed by fluorescence-based anion exchange high performance liquid chromatography to separate and quantitate nonreducing terminal structures, in addition to internal unsaturated disaccharide products. The predominant terminal structures were the monosaccharides, GalNAc4S and GalNAc4,6S as they were present on 85-90% of all chains. The remaining chains terminated with the disaccharides GlcAbeta1,3GalNAc4S and GlcAbeta1,3GalNAc6S. Marked changes in the relative abundance of these terminals were identified in the transition from growth cartilage to adult articular cartilage. First, terminal GalNAc residues were almost exclusively 4-sulfated in aggrecan from fetal through 15 years of age, but were approximately 50% 4,6-disulfated in aggrecans from adults (22-72 years of age). Second, the terminal disaccharide GlcAbeta1,3GalNAc4S was on approximately 7% of chains on aggrecan from fetal through 15 years of age, but on only approximately 3% of chains on adult aggrecan. In contrast, the proportion of chains terminating in GlcAbeta1,3GalNAc6S, approximately 9%, was unchanged from fetal to 72 years of age. This terminal disaccharide is proposed to be recognized by the widely used monoclonal antibody 3B3. However, chemical quantitation of the structure together with solid phase 3B3(-) immunoassay of fetal and adult aggrecans showed that the content of the terminal disaccharide does not necessarily correlate with immunoreactivity of the proteoglycan, as chain density and presentation on the solid phase are critical factors for recognition of chain terminals by 3B3. The quantitative results obtained from chemical analyses of all nonreducing termini of aggrecan chondroitin sulfate chains revealed important changes in chain termination that occur when cellular activities are altered as adult articular cartilage is formed after removal of growth cartilage. These findings are discussed in relation to specific enzymatic steps that generate the nonreducing termini of chains in the biosynthesis pathway of chondroitin sulfate proteoglycans and their modulation in tissue development and pathology.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9252375     DOI: 10.1074/jbc.272.33.20603

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  LC-MS/MS characterization of xyloside-primed glycosaminoglycans with cytotoxic properties reveals structural diversity and novel glycan modifications.

Authors:  Andrea Persson; Alejandro Gomez Toledo; Egor Vorontsov; Waqas Nasir; Daniel Willén; Fredrik Noborn; Ulf Ellervik; Katrin Mani; Jonas Nilsson; Göran Larson
Journal:  J Biol Chem       Date:  2018-05-08       Impact factor: 5.157

2.  Analysis of glycosaminoglycans in stem cell glycomics.

Authors:  Boyangzi Li; Haiying Liu; Zhenqing Zhang; Hope E Stansfield; Jonathan S Dordick; Robert J Linhardt
Journal:  Methods Mol Biol       Date:  2011

3.  Involvement of human natural killer-1 (HNK-1) sulfotransferase in the biosynthesis of the GlcUA(3-O-sulfate)-Gal-Gal-Xyl tetrasaccharide found in α-thrombomodulin from human urine.

Authors:  Taishi Hashiguchi; Shuji Mizumoto; Yuko Nishimura; Jun-ichi Tamura; Shuhei Yamada; Kazuyuki Sugahara
Journal:  J Biol Chem       Date:  2011-08-02       Impact factor: 5.157

4.  Adamts5 deletion blocks murine dermal repair through CD44-mediated aggrecan accumulation and modulation of transforming growth factor β1 (TGFβ1) signaling.

Authors:  Jennifer Velasco; Jun Li; Luisa DiPietro; Mary Ann Stepp; John D Sandy; Anna Plaas
Journal:  J Biol Chem       Date:  2011-05-12       Impact factor: 5.157

5.  The role of vascular-derived perlecan in modulating cell adhesion, proliferation and growth factor signaling.

Authors:  Megan S Lord; Christine Y Chuang; James Melrose; Michael J Davies; Renato V Iozzo; John M Whitelock
Journal:  Matrix Biol       Date:  2014-02-06       Impact factor: 11.583

6.  Increased incidence of unsulphated and 4-sulphated residues in the chondroitin sulphate linkage region observed by high-pH anion-exchange chromatography.

Authors:  R M Lauder; T N Huckerby; I A Nieduszynski
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

7.  Synovial fluid chondroitin sulphate epitopes 3B3 and 7D4, and glycosaminoglycan in human knee osteoarthritis after exercise.

Authors:  J C Bautch; M K Clayton; Q Chu; K A Johnson
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

Review 8.  Chondrodysplasia of gene knockout mice for aggrecan and link protein.

Authors:  Hideto Watanabe; Yoshihiko Yamada
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

9.  Tandem mass spectrometric strategies for determination of sulfation positions and uronic acid epimerization in chondroitin sulfate oligosaccharides.

Authors:  Joseph Zaia; Xue-Qing Li; Shiu-Yung Chan; Catherine E Costello
Journal:  J Am Soc Mass Spectrom       Date:  2003-11       Impact factor: 3.109

10.  Inhibition of N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase by beta-D-4-O-sulfo-N-acetylgalactosaminides bearing various hydrophobic aglycons.

Authors:  Hiroko Nozaki; Yuri Tomoyama; Hideyuki Takagi; Koutaro Yokoyama; Chika Yamada; Ken-ichi Kaio; Masaki Tsukimori; Kazuya Nagao; Yuya Itakura; Shiori Ohtake-Niimi; Hirofumi Nakano; Osami Habuchi
Journal:  Glycoconj J       Date:  2009-12-18       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.